Keith Daniels Kaufman MD
Diabetes, Lipid Metabolism
Vice President, Project Leadership & Management, Merck Research Laboratories
Join to View Full Profile
PO Box 2000RY34-A4063Rahway, NJ 07065
Dr. Kaufman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1989- University of California San Francisco School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1986 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: a Phase 2a Study in Participants at Low Risk for Acquiring HIV-1.Sharon L Hillier, Linda-Gail Bekker, Sharon A Riddler, Craig W Hendrix, Sharlaa Badal-Faesen
The Journal of Infectious Diseases. 2025-05-06 - Clinical Trial: A Phase 2b Study to Evaluate the Efficacy and Safety of MK-3655 in Individuals With Pre-Cirrhotic MASH.Annaswamy Raji, Ira Gantz, Michael Crutchlow, Heather Flynn, Lianzhe Xu
Alimentary Pharmacology & Therapeutics. 2025-04-01 - 67 citationsA phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease.Manuel Romero-Gómez, Eric Lawitz, R Ravi Shankar, Eirum Chaudhri, Jie Liu
Journal of Hepatology. 2023-10-01
Journal Articles
- A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in Patients with Type 2 Diabetes Mellitus and Mild Renal Insufficienc...Keith Kaufman, MD, Diabetes, Obesity and Metabolism
Press Mentions
Court Let Merck Hide Secrets About Baldness Drug’s RisksSeptember 11th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
